Latest news with #ZacksInvestmentResearch
Yahoo
2 hours ago
- Business
- Yahoo
Synopsys (SNPS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended April 2025, Synopsys (SNPS) reported revenue of $1.6 billion, up 10.3% over the same period last year. EPS came in at $3.67, compared to $3.00 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.6 billion, representing a surprise of +0.16%. The company delivered an EPS surprise of +8.26%, with the consensus EPS estimate being $3.39. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Synopsys performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Maintenance and service: $265.26 million versus $279.24 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -4.1% change. Revenue- Total products revenue: $1.34 billion compared to the $1.32 billion average estimate based on four analysts. The reported number represents a change of +13.7% year over year. Revenue by segment- Design IP: $482 million compared to the $443.37 million average estimate based on three analysts. The reported number represents a change of +20.6% year over year. Revenue by segment- Design Automation: $1.12 billion compared to the $1.16 billion average estimate based on three analysts. The reported number represents a change of +6.4% year over year. Revenue- Upfront products: $510.68 million versus the three-analyst average estimate of $415.15 million. The reported number represents a year-over-year change of +28.8%. Revenue- Time-based products: $828.33 million compared to the $904.12 million average estimate based on three analysts. The reported number represents a change of +6% year over year. View all Key Company Metrics for Synopsys here>>>Shares of Synopsys have returned +11.1% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synopsys, Inc. (SNPS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Business
- Yahoo
Nutanix (NTNX) Reports Q3 Earnings: What Key Metrics Have to Say
Nutanix (NTNX) reported $638.98 million in revenue for the quarter ended April 2025, representing a year-over-year increase of 21.8%. EPS of $0.42 for the same period compares to $0.28 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $626.12 million, representing a surprise of +2.06%. The company delivered an EPS surprise of +10.53%, with the consensus EPS estimate being $0.38. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Nutanix performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total Billings: $647.05 million compared to the $676.02 million average estimate based on four analysts. Annual Recurring Revenue (ARR): $2.14 billion compared to the $2.17 billion average estimate based on four analysts. Disaggregation of billings - Professional services billings: $18.48 million versus the three-analyst average estimate of $32.78 million. Disaggregation of billings - Subscription billings: $627.25 million compared to the $616.58 million average estimate based on two analysts. Disaggregation of billings - Other non-subscription product billings: $1.32 million versus the two-analyst average estimate of $1.68 million. Revenue- Support, entitlements and other services: $293.50 million versus the eight-analyst average estimate of $312.03 million. The reported number represents a year-over-year change of +9.1%. Revenue- Product: $345.48 million versus $310.26 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +35.2% change. Disaggregation of Revenue- Professional services revenue: $28 million versus the seven-analyst average estimate of $28.12 million. The reported number represents a year-over-year change of +6.7%. Disaggregation of Revenue- Subscription revenue: $609.66 million versus $594.37 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +25.3% change. Disaggregation of Revenue- Non-portable software revenue: $0.50 million versus $2.59 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -95.5% change. View all Key Company Metrics for Nutanix here>>>Shares of Nutanix have returned +15.3% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nutanix (NTNX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Business
- Yahoo
Here's Why AZZ (AZZ) Fell More Than Broader Market
AZZ (AZZ) closed the latest trading day at $89.93, indicating a -1.46% change from the previous session's end. The stock's performance was behind the S&P 500's daily loss of 0.56%. Elsewhere, the Dow lost 0.58%, while the tech-heavy Nasdaq lost 0.51%. Shares of the electrical equipment maker witnessed a gain of 3.54% over the previous month, trailing the performance of the Industrial Products sector with its gain of 9.95% and the S&P 500's gain of 7.37%. Investors will be eagerly watching for the performance of AZZ in its upcoming earnings disclosure. The company is forecasted to report an EPS of $1.56, showcasing a 6.85% upward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $440.52 million, indicating a 6.61% growth compared to the corresponding quarter of the prior year. AZZ's full-year Zacks Consensus Estimates are calling for earnings of $5.71 per share and revenue of $1.69 billion. These results would represent year-over-year changes of +9.81% and +7.26%, respectively. Investors should also pay attention to any latest changes in analyst estimates for AZZ. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. At present, AZZ boasts a Zacks Rank of #3 (Hold). From a valuation perspective, AZZ is currently exchanging hands at a Forward P/E ratio of 15.98. This expresses a discount compared to the average Forward P/E of 21.19 of its industry. The Manufacturing - Electronics industry is part of the Industrial Products sector. This industry, currently bearing a Zacks Industry Rank of 83, finds itself in the top 34% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AZZ Inc. (AZZ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 hours ago
- Business
- Yahoo
Veeva (VEEV) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended April 2025, Veeva Systems (VEEV) reported revenue of $759.04 million, up 16.7% over the same period last year. EPS came in at $1.97, compared to $1.50 in the year-ago quarter. The reported revenue represents a surprise of +4.27% over the Zacks Consensus Estimate of $727.99 million. With the consensus EPS estimate being $1.74, the EPS surprise was +13.22%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Veeva performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Non-GAAP Gross Margin- Professional Services and other: 33.6% versus 26.6% estimated by nine analysts on average. Non-GAAP Gross Margin- Subscription services: 88.1% versus 86% estimated by nine analysts on average. Revenues- Subscription services: $634.77 million compared to the $615.93 million average estimate based on 10 analysts. The reported number represents a change of +18.9% year over year. Revenues- Professional services and other: $124.28 million compared to the $112.07 million average estimate based on 10 analysts. The reported number represents a change of +6.8% year over year. Revenues- Professional services and other- Veeva R&D Solutions: $77.71 million versus $64.87 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +14.9% change. Revenues- Subscription services- Veeva R&D Solutions: $329.36 million versus $328.16 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +20.8% change. Revenues- Subscription services- Veeva Commercial Solutions: $305.41 million compared to the $287.80 million average estimate based on five analysts. The reported number represents a change of +16.9% year over year. Revenues- Professional services and other- Veeva Commercial Solutions: $46.57 million versus the five-analyst average estimate of $46.98 million. The reported number represents a year-over-year change of -4.5%. View all Key Company Metrics for Veeva here>>>Shares of Veeva have returned +2.8% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Veeva Systems Inc. (VEEV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 hours ago
- Business
- Yahoo
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
For the quarter ended April 2025, Agilent Technologies (A) reported revenue of $1.67 billion, up 6% over the same period last year. EPS came in at $1.31, compared to $1.22 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.63 billion, representing a surprise of +2.64%. The company delivered an EPS surprise of +3.97%, with the consensus EPS estimate being $1.26. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue by End Markets- Pharmaceutical: $603 million versus the two-analyst average estimate of $572.63 million. The reported number represents a year-over-year change of +11.3%. Revenue by End Markets- Academia and Government: $135 million compared to the $145.13 million average estimate based on two analysts. The reported number represents a change of -2.9% year over year. Revenue by End Markets- Diagnostics and Clinical: $255 million versus the two-analyst average estimate of $247.93 million. The reported number represents a year-over-year change of +6.7%. Net Revenue- Agilent Crosslab Group: $713 million versus $697.53 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +77.4% change. Revenue by End Markets- Food: $147 million versus $146.05 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change. Revenue by End Markets- Environmental and Forensics: $159 million compared to the $159.54 million average estimate based on two analysts. The reported number represents a change of +4.6% year over year. Revenue by End Markets- Chemical and advanced materials: $369 million compared to the $370.20 million average estimate based on two analysts. The reported number represents a change of +1.9% year over year. View all Key Company Metrics for Agilent here>>>Shares of Agilent have returned +3.5% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
